New US Guidelines May Affect How Young Adults Manage ‘Bad’ Cholesterol

Updated U.S. cholesterol guidelines could make 21.5 million more adults eligible for statin therapy, expanding preventive treatment considerations for cardiovascular disease.

A study published in JAMA found that an estimated 87.5 million adults ages 30 to 79, or nearly 57% of the population studied, may qualify for statins under the new recommendations. The expanded eligibility reflects broader age ranges, lower risk thresholds, and greater consideration of conditions such as chronic kidney disease and HIV.

The changes highlight the importance of individualized risk assessments and discussions between patients and providers when considering cholesterol-lowering treatment. Read the full article from CNN here.